Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

European Court of Justice restricts scope of biotech patents in Europe: Monsanto loses dispute on soy meal

Jones Day
-
European Union
-
July 19 2010

The European Court of Justice delivered a judgment on July 6, 2010 that certainly may be seen as a breakthrough decision for European biotechnology patent law

Methods of treatment in Europe: patent claims covering second or further medical uses and dosage regimens

Jones Day
-
European Union
-
November 18 2010

The decision G 208 of February 19, 2010 (published October 28, 2010) of the Enlarged Board of Appeal (EBA) of the European Patent Office confirms that a substance or composition known as a medicament for treating a certain illness can be patented for use in a different treatment by therapy of the same disease

No clear pointer in the right direction: validity issues in Europe of patent term extensions covering fixed-combination medicinal products

Jones Day
-
European Union
-
February 8 2011

Pitfalls loom when applying for patent term extensions covering fixed combination medicinal products

New EPO information disclosure requirements entering into effect on January 1, 2011

Jones Day
-
European Union
-
December 7 2010

According to the European Patent Convention's current Implementing Regulations, an inventor applying for a European patent may be invited by the European Patent Office ("EPO") to submit information on prior art that was taken into consideration in the examination of related national or regional patent applications

Europe's highest court decides on patent term extensions for fixed-combination medicinal products

Jones Day
-
European Union, United Kingdom
-
December 21 2011

Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European courtthe Court of Justice of the European Union

A therapy for European patent term extensions: the Neurim case and supplementary protection certificates for "new therapeutic applications"

Jones Day
-
European Union
-
July 30 2012

On July 19, 2012, the Court of Justice of the European Union ("CJEU") issued its long-awaited decision in case C-13011 Neurim Pharmaceuticals (1991) Ltd v. Comptroller-General of Patents

Europe's landmark decision on stem cell patents, or: the strict European view on life

Jones Day
-
European Union
-
October 31 2011

In a landmark decision on October 18, 2011, the highest court of the European Unionthe Court of Justicedecided on the patentability of stem-cell-related inventions (case number C-3410

Search results

European Court of Justice restricts scope of biotech patents in Europe: Monsanto loses dispute on soy meal

Methods of treatment in Europe: patent claims covering second or further medical uses and dosage regimens

No clear pointer in the right direction: validity issues in Europe of patent term extensions covering fixed-combination medicinal products

New EPO information disclosure requirements entering into effect on January 1, 2011

Europe's highest court decides on patent term extensions for fixed-combination medicinal products

A therapy for European patent term extensions: the Neurim case and supplementary protection certificates for "new therapeutic applications"

Europe's landmark decision on stem cell patents, or: the strict European view on life

Current Search

Suggested Facets

Author

Workarea